These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study. Di Trapani G, Mei D, Marra C, Mazza S, Capuano A. Clin Ter; 2000; 151(3):145-8. PubMed ID: 10958046 [Abstract] [Full Text] [Related]
5. Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia. Parsons B, Tive L, Huang S. Am J Geriatr Pharmacother; 2004 Sep; 2(3):157-62. PubMed ID: 15561647 [Abstract] [Full Text] [Related]
6. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Spira PJ, Beran RG, Australian Gabapentin Chronic Daily Headache Group. Neurology; 2003 Dec 23; 61(12):1753-9. PubMed ID: 14694042 [Abstract] [Full Text] [Related]
7. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial. Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP, Study Group. Headache; 2009 Feb 23; 49(2):216-26. PubMed ID: 19222595 [Abstract] [Full Text] [Related]
8. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. JAMA; 1998 Dec 02; 280(21):1831-6. PubMed ID: 9846777 [Abstract] [Full Text] [Related]
9. [Effectiveness and safety of gabapentin in the preventive treatment of migraine]. Jiménez-Hernández MD, Torrecillas Nárvaez MD, Friera Acebal G. Rev Neurol; 1998 Dec 02; 35(7):603-6. PubMed ID: 12389143 [Abstract] [Full Text] [Related]
10. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Serpell MG, Neuropathic Pain Study Group. Pain; 2002 Oct 02; 99(3):557-566. PubMed ID: 12406532 [Abstract] [Full Text] [Related]
11. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ, TOPMAT-MIG-201(TOP-CHROME) Study Group. Cephalalgia; 2007 Jul 02; 27(7):814-23. PubMed ID: 17441971 [Abstract] [Full Text] [Related]
13. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group. Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B. Epilepsia; 1994 Jul 02; 35(4):795-801. PubMed ID: 8082624 [Abstract] [Full Text] [Related]
14. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group. Headache; 2007 Apr 02; 47(4):486-99. PubMed ID: 17445098 [Abstract] [Full Text] [Related]
15. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group. Appleton R, Fichtner K, LaMoreaux L, Alexander J, Halsall G, Murray G, Garofalo E. Epilepsia; 1999 Aug 02; 40(8):1147-54. PubMed ID: 10448830 [Abstract] [Full Text] [Related]
20. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC. Headache; 2011 Oct 02; 51(9):1358-73. PubMed ID: 21883197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]